SENORES
Invest with MTF
Invest Now
Invest in Senores Pharmaceuticals with 3.04X leverage
Performance
- Low
- ₹800
- High
- ₹821
- 52 Week Low
- ₹440
- 52 Week High
- ₹877
- Open Price₹815
- Previous Close₹818
- Volume95,306
- 50 DMA₹804.03
- 100 DMA₹775.47
- 200 DMA₹707.81
Investment Returns
- Over 1 Month -1.04%
- Over 3 Month + 4.96%
- Over 6 Month + 21.34%
- Over 1 Year + 55.95%
Smart Investing Starts Here Start SIP with Senores Pharmaceuticals for Steady Growth!
Senores Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 36.4
- PEG Ratio
- 0.6
- Market Cap Cr
- 3,698
- P/B Ratio
- 4.5
- Average True Range
- 29.41
- EPS
- 22.06
- Dividend Yield
- 0
- MACD Signal
- 1.02
- RSI
- 47.36
- MFI
- 56.57
Senores Pharmaceuticals Financials
Senores Pharmaceuticals Technicals
EMA & SMA
Current Price
₹803.00
-14.7
(-1.8%)
- Bearish Moving Average 11
- Bullish Moving Average 5
- 20 Day
- ₹812.03
- 50 Day
- ₹804.03
- 100 Day
- ₹775.47
- 200 Day
- ₹707.81
Resistance and Support
808
- R3 837.00
- R2 829.00
- R1 816.00
- S1 795.00
- S2 787.00
- S3 774.00
Senores Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-01-20 | Quarterly Results & Others | To consider other business matters. |
| 2026-01-07 | Others | Inter alia, 1. To consider and evaluate proposals for raising funds by way of issue of convertible warrants on preferential basis to the promotors/promoter group. |
| 2025-11-06 | Quarterly Results | |
| 2025-07-23 | Quarterly Results & Others | To consider other business matters. |
| 2025-05-15 | Audited Results |
Senores Pharmaceuticals F&O
About Senores Pharmaceuticals
- NSE Symbol
- SENORES
- BSE Symbol
- 544319
- Managing Director
- Mr. Swapnil Jatinbhai Shah
- ISIN
- INE0RB801010
Similar Stocks to Senores Pharmaceuticals
Senores Pharmaceuticals FAQs
Senores Pharmaceuticals share price is ₹803 As on 12 February, 2026 | 19:47
The Market Cap of Senores Pharmaceuticals is ₹3698.1 Cr As on 12 February, 2026 | 19:47
The P/E ratio of Senores Pharmaceuticals is 36.4 As on 12 February, 2026 | 19:47
The PB ratio of Senores Pharmaceuticals is 4.5 As on 12 February, 2026 | 19:47
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.